On 23 march 2018, an email was received from an eye care professional (ecp).The email contained an attached summary data spreadsheet containing the medical information for subjects involved in the study of acanthamoeba keratitis conducted in the uk.The information received from the ecp included only those study subjects who reported wearing acuvue brand products at the time of the adverse event.All the study subjects were initially examined and diagnosed with acanthamoeba keratitis during 2011-2014.The patient (pt), study id (b)(6), presented to the hospital on (b)(6) 2014 with severe photophobia, redness and pain.The pt was diagnosed with acanthamoeba keratitis.The pt reported wearing acuvue advance brand or acuvue oasys brand contact lenses, it was unknown which acuvue brand the pt was wearing at the time of the event.The pt presented to the hospital on (b)(6) 2014 with severe photophobia, redness and pain od.Pt also reported sleeping in the lenses 6 nights/year, 1 night in a row, showered in the lenses and did not dry hands after washing.Pt also reported using synergi solution.Pt was treated with antiamoebics for 4 months.Va: 6/6 (20/20).No additional information is expected to be received.It is unknown which acuvue brand was the suspect product.The suspect product is not available for return for evaluation.If additional information is received it will be reported within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|